Report Detail
Global Prostate Cancer Diagnostics Market Research Report 2012-2024
- RnM3629570 |
- 29 July, 2019 |
- Global |
- 77 Pages |
- HeyReport |
- Other
Summary
The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer.
The global Prostate Cancer Diagnostics market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Tumor Biomarker Tests
Imaging
Biopsy
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Genomic Health
Abbott
OPKO
Siemens Healthcare
DiaSorin
bioMeriux
Roche
MDx Health
Beckman Coulter
Myriad Genetics
Ambry Genetics
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
< 55
55-75
> 75
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Table of Contents
1 Market Overview
- 1.1 Objectives of Research
- 1.1.1 Definition
- 1.1.2 Specifications
- 1.2 Market Segment
- 1.2.1 by Type
- 1.2.1.1 Tumor Biomarker Tests
- 1.2.1.2 Imaging
- 1.2.1.3 Biopsy
- 1.2.1.4 Others
- 1.2.2 by Application
- 1.2.2.1 < 55
- 1.2.2.2 55-75
- 1.2.2.3 > 75
- 1.2.3 by Regions
- 1.2.1 by Type
2 Industry Chain
- 2.1 Industry Chain Structure
- 2.2 Upstream
- 2.3 Market
- 2.3.1 SWOT
- 2.3.2 Dynamics
3 Environmental Analysis
- 3.1 Policy
- 3.2 Economic
- 3.3 Technology
- 3.4 Market Entry
4 Market Segmentation by Type
- 4.1 Market Size
- 4.1.1 Tumor Biomarker Tests Market, 2013-2018
- 4.1.2 Imaging Market, 2013-2018
- 4.1.3 Biopsy Market, 2013-2018
- 4.1.4 Others Market, 2013-2018
- 4.2 Market Forecast
- 4.2.1 Tumor Biomarker Tests Market Forecast, 2019-2024
- 4.2.2 Imaging Market Forecast, 2019-2024
- 4.2.3 Biopsy Market Forecast, 2019-2024
- 4.2.4 Others Market Forecast, 2019-2024
5 Market Segmentation by Application
- 5.1 Market Size
- 5.1.1 < 55 Market, 2013-2018
- 5.1.2 55-75 Market, 2013-2018
- 5.1.3 > 75 Market, 2013-2018
- 5.2 Market Forecast
- 5.2.1 < 55 Market Forecast, 2019-2024
- 5.2.2 55-75 Market Forecast, 2019-2024
- 5.2.3 > 75 Market Forecast, 2019-2024
6 Market Segmentation by Region
- 6.1 Market Size
- 6.1.1 Asia-Pacific
- 6.1.1.1 Asia-Pacific Market, 2012-2018
- 6.1.1.2 Asia-Pacific Market by Type
- 6.1.1.3 Asia-Pacific Market by Application
- 6.1.2 North America
- 6.1.2.1 North America Market, 2012-2018
- 6.1.2.2 North America Market by Type
- 6.1.2.3 North America Market by Application
- 6.1.3 Europe
- 6.1.3.1 Europe Market, 2012-2018
- 6.1.3.2 Europe Market by Type
- 6.1.3.3 Europe Market by Application
- 6.1.4 South America
- 6.1.4.1 South America Market, 2012-2018
- 6.1.4.2 South America Market by Type
- 6.1.4.3 South America Market by Application
- 6.1.5 Middle East & Africa
- 6.1.5.1 Middle East & Africa Market, 2012-2018
- 6.1.5.2 Middle East & Africa Market by Type
- 6.1.5.3 Middle East & Africa Market by Application
- 6.1.1 Asia-Pacific
- 6.2 Market Forecast
- 6.2.1 Asia-Pacific Market Forecast, 2019-2024
- 6.2.2 North America Market Forecast, 2019-2024
- 6.2.3 Europe Market Forecast, 2019-2024
- 6.2.4 South America Market Forecast, 2019-2024
- 6.2.5 Middle East & Africa Market Forecast, 2019-2024
7 Market Competitive
- 7.1 Global Market by Vendors
- 7.2 Market Concentration
- 7.3 Price & Factors
- 7.4 Marketing Channel
8 Major Vendors
- 8.1 Genomic Health
- 8.2 Abbott
- 8.3 OPKO
- 8.4 Siemens Healthcare
- 8.5 DiaSorin
- 8.6 bioMeriux
- 8.7 Roche
- 8.8 MDx Health
- 8.9 Beckman Coulter
- 8.10 Myriad Genetics
- 8.11 Ambry Genetics
9 Conclusion
Summary:
Get latest Market Research Reports on Prostate Cancer Diagnostics. Industry analysis & Market Report on Prostate Cancer Diagnostics is a syndicated market report, published as Global Prostate Cancer Diagnostics Market Research Report 2012-2024. It is complete Research Study and Industry Analysis of Prostate Cancer Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
